全文获取类型
收费全文 | 5670篇 |
免费 | 529篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 153篇 |
妇产科学 | 88篇 |
基础医学 | 797篇 |
口腔科学 | 113篇 |
临床医学 | 506篇 |
内科学 | 886篇 |
皮肤病学 | 69篇 |
神经病学 | 436篇 |
特种医学 | 219篇 |
外科学 | 1141篇 |
综合类 | 153篇 |
一般理论 | 33篇 |
预防医学 | 443篇 |
眼科学 | 70篇 |
药学 | 590篇 |
中国医学 | 10篇 |
肿瘤学 | 461篇 |
出版年
2023年 | 31篇 |
2022年 | 41篇 |
2021年 | 81篇 |
2020年 | 44篇 |
2019年 | 75篇 |
2018年 | 92篇 |
2017年 | 63篇 |
2016年 | 79篇 |
2015年 | 105篇 |
2014年 | 133篇 |
2013年 | 197篇 |
2012年 | 278篇 |
2011年 | 296篇 |
2010年 | 170篇 |
2009年 | 156篇 |
2008年 | 228篇 |
2007年 | 253篇 |
2006年 | 295篇 |
2005年 | 277篇 |
2004年 | 267篇 |
2003年 | 250篇 |
2002年 | 225篇 |
2001年 | 193篇 |
2000年 | 209篇 |
1999年 | 179篇 |
1998年 | 84篇 |
1997年 | 79篇 |
1996年 | 69篇 |
1995年 | 68篇 |
1994年 | 70篇 |
1993年 | 68篇 |
1992年 | 131篇 |
1991年 | 122篇 |
1990年 | 107篇 |
1989年 | 93篇 |
1988年 | 109篇 |
1987年 | 80篇 |
1986年 | 84篇 |
1985年 | 67篇 |
1984年 | 67篇 |
1983年 | 53篇 |
1982年 | 41篇 |
1980年 | 37篇 |
1979年 | 56篇 |
1978年 | 45篇 |
1977年 | 46篇 |
1976年 | 39篇 |
1975年 | 40篇 |
1974年 | 36篇 |
1973年 | 48篇 |
排序方式: 共有6210条查询结果,搜索用时 0 毫秒
1.
2.
PURPOSE: Angiotensin converting enzyme inhibitors (ACEIs) are a group of drugs used to treat hypertension and heart failure, with additional benefits, such as cardiovascular and renal protection, in patients with diabetes. However, angioedema as a complication of ACEI therapy is under-recognized. As there are important implications for anesthesiologists and emergency medicine physicians, a review was undertaken to document the scope of the problem of ACEI-induced angioedema.. METHODS: A review of the published literature (identified by searching Medline, EMBASE and CINAHL) was undertaken, addressing the clinical uses of ACEIs and the incidence, risk factors, pathophysiology, clinical presentation and management of angioedema associated with the use of these drugs. PRINCIPAL FINDINGS: The incidence of ACEI related angioedema has increased from 0.1-0.2% to 1% over the last decade. Patients who are receiving ACEIs are predisposed to developing angioedema which may be triggered by trauma, airway instrumentation, infection, and irritant fumes, particularly in those who are at increased risk. Cases of acute facial and airway oedema, due to ACEI drug administration, may be misdiagnosed as an anaphylactic reaction, and the association with ACEIs may be ignored. Some cases of intraoperative and postoperative airway edema may be precipitated by airway instrumentation in patients receiving ACEI drugs. The severity of airway compromise ranges from mild facial edema to severe laryngeal or subglottic edema which may prove life-threatening. CONCLUSION: In view of the widespread clinical indications and ever-increasing use of ACEI drugs, the potentially life-threatening adverse reaction of ACEI-associated angioedema, and its treatment, must be recognized by anesthesiologists and all clinicians involved in airway management. 相似文献
3.
4.
5.
Graham M Nicholson 《Toxicon》2007,49(4):413-422
Arthropod pests are responsible for major crop devastation and are vectors for the transmission of new and re-emerging diseases in humans and livestock. Despite many years of effective control by conventional agrochemical insecticides, a number of factors are threatening the effectiveness and continued use of these agents. These include the development of insecticide resistance and use-cancellation or de-registration of some insecticides due to human health and environmental concerns. Several approaches are being investigated for the design of new (bio)pesticides. These include the development of transgenic plants and recombinant baculoviruses as delivery systems for a variety of insect-selective toxins. Additional approaches for the development of foliar sprays include the rational design of peptidomimetics based on the key residues of these toxins that interact with the insect target. This special issue provides an overview of these phyletically selective animal, plant and microbial toxins and their diverse mechanisms of action to paralyze or kill arthropods. In addition, it reviews their potential for biopesticide discovery and validation of novel insecticide targets and provides an overview of the strengths and weaknesses of biopesticides in the global control of arthropod pests. 相似文献
6.
7.
Susan Goldstein Garth Japhet S. Usdin E. Scheepers 《Health promotion journal of Australia》2004,15(2):114-120
This paper outlines the programming model employed by the Soul City Institute for Health and Development Communication, a South African NGO, in using ‘edutainment’ to facilitate social change. The paper refers to the intersection of this model and current thought on health promotion and various social change theories. It also discusses key challenges and factors contributing to sustainability over 12 years. 相似文献
8.
Donald B. Penzien PhD ; Frank Andrasik PhD ; Brian M. Freidenberg PhD ; Timothy T. Houle PhD ; Alvin E. Lake III PhD; Gay L. Lipchik PhD ; Kenneth A. Holroyd PhD ; Richard B. Lipton MD ; Douglas C. McCrory MD ; Justin M. Nash PhD ; Robert A. Nicholson PhD ; Scott W. Powers PhD ABPP ; Jeanetta C. Rains PhD ; David A. Wittrock PhD 《Headache》2005,45(S2):S110-S132
Guidelines for design of clinical trials evaluating behavioral headache treatments were developed to facilitate production of quality research evaluating behavioral therapies for management of primary headache disorders. These guidelines were produced by a Workgroup of headache researchers under auspices of the American Headache Society. The guidelines are complementary to and modeled after guidelines for pharmacological trials published by the International Headache Society, but they address methodologic considerations unique to behavioral and other nonpharmacological treatments. Explicit guidelines for evaluating behavioral headache therapies are needed as the optimal methodology for behavioral (and other nonpharmacologic) trials necessarily differs from the preferred methodology for drug trials. In addition, trials comparing and integrating drug and behavioral therapies present methodological challenges not addressed by guidelines for pharmacologic research. These guidelines address patient selection, trial design for behavioral treatments and for comparisons across multiple treatment modalities (eg, behavioral vs pharmacologic), evaluation of results, and research ethics. Although developed specifically for behavioral therapies, the guidelines may apply to the design of clinical trials evaluating many forms of nonpharmacologic therapies for headache. 相似文献
9.
OBJECTIVE: To estimate the gestational age ranges that result in optimal birth outcomes for each of four risk-defined groups. STUDY DESIGN: Retrospective cohort study of singleton late third-trimester deliveries at a large urban teaching hospital between July 1995 and September 2003. Low-risk, advanced maternal age, hypertensive and diabetic patients were identified and grouped. Rates, by day of gestation at delivery, of cesarean delivery, major maternal perineal trauma, low 5-min APGAR score and NICU admission were determined for each study group. RESULTS: Each study group had meaningful changes in rates of obstetric outcomes as a function of gestational age at delivery and these patterns differed from group to group. A unique optimal time of delivery (OTD) was estimated for each group. The low-risk group OTD was calculated to be 37 weeks 1 day to 41 weeks 0 day; the advanced maternal age group OTD was 38 weeks 5 days to 39 weeks 6 days; the hypertension group OTD was 39 weeks 2 days to 40 weeks 1 day; and the diabetes mellitus group OTD was 40 weeks 3 days to 41 weeks 1 day. CONCLUSIONS: The OTD varied based on obstetrical risk. Strategies to increase the proportion of deliveries that occur within the OTD for specific risk-defined groups could theoretically improve birth outcomes. 相似文献
10.